Gene: CCDC195
Official Full Name: coiled-coil domain containing 195provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18931 | CCDC195 Knockout cell line (HeLa) | Human | CCDC195 | 1:3~1:6 | Negative | Online Inquiry |
KO18932 | CCDC195 Knockout cell line (HCT 116) | Human | CCDC195 | 1:2~1:4 | Negative | Online Inquiry |
KO18933 | CCDC195 Knockout cell line (A549) | Human | CCDC195 | 1:3~1:4 | Negative | Online Inquiry |
CCDC195 Gene Knockout Cell Lines are genetically engineered cellular models designed to elucidate the functional role of the CCDC195 gene, a critical component implicated in various biological processes, including cellular trafficking and cytoskeletal dynamics. These cell lines have been meticulously developed using CRISPR/Cas9 technology, allowing for precise and efficient disruption of the CCDC195 gene, enabling researchers to investigate its specific contributions to cellular function and pathology.
The primary mechanism underlying these knockout cell lines involves the introduction of targeted mutations within the CCDC195 gene, effectively abolishing its expression. This gene disruption facilitates in-depth exploration of the gene’s involvement in cellular processes, such as vesicle transport and cell signaling pathways. Researchers can utilize these models to study disease mechanisms, identify potential therapeutic targets, and evaluate drug responses, particularly in drug-resistant cell populations.
The scientific significance of CCDC195 Gene Knockout Cell Lines cannot be overstated, as they provide valuable insights relevant to various fields such as molecular biology, cancer research, and regenerative medicine. Their application extends to high-throughput screening for novel therapeutic compounds and the assessment of gene function in both normal and pathological states, making them indispensable tools for both academic and industrial researchers.
What sets our CCDC195 Gene Knockout Cell Lines apart from alternative models is their validation with rigorous quality control measures, ensuring consistent performance in assays. Furthermore, they offer a more straightforward experimental approach compared to transient knockdown methods, as they establish stable cell lines that can be utilized over multiple passages, enhancing experimental reproducibility.
Purchasing these cell lines translates into significant value for researchers and clinicians who require reliable and robust models to advance their studies. Equipped with an extensive background in genetic engineering and cellular biology, our company is committed to providing high-quality biological products that empower scientific discovery and innovation, enabling our customers to achieve their research goals with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.